Article No
30-1190-0.1
HIV protease
Anti-HIV protease Monoclonal Antibody (Clone:1696)
Antibodies Primary
Specifications
| Application | ELISA, FA, WB |
| Article No | 30-1190-0.1 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Clone | 1696 |
| Clone Type | monoclonal |
| Conjugation | Unconjugated |
| Description | Anti-HIV protease Monoclonal Antibody (Clone:1696) |
| Supplier | Abeomics |
| Immunogen | Bacterially expressed full-length HIV-1 protease |
| Isotype | IgG1 |
| Notes | The HIV protease (PR) hydrolyzes polyproteins of HIV virus into functional protein products that are essential for its assembly and subsequent activity. This maturation process occurs as the virion buds from the host cell. HIV protease inhibitors are used in the treatment of patients with AIDS and were considered the first breakthrough in over a decade of AIDS research. HIV protease inhibitors can lower the viral load carried by AIDS patents. |
| Product Type | Antibodies Primary |
| Protocol | Western Blotting Recommended dilution: 0.5 µg/ml |
| Purification | Protein A Purified |
| Shipping Information | Blue Ice |
| Size | 0.1 mg |
| Source / Host | mouse |
| Species Reactivity | virus |
| Storage | 4°C |
| Product Page Updated | 2024-02-06T07:35:53.072Z |
